Transactions
Biogen, Inc.’s sale of its 49.9% stake in Samsung Bioepis to Samsung Biologics
Date Announced:
01/27/2022
client:
Biogen, Inc.
Status:
Closed – 04/20/2022
Value:
$2.3 billion
Date Announced:
01/27/2022
client:
Biogen, Inc.
Status:
Closed – 04/20/2022
Value:
$2.3 billion